Selective KCa2.2 and KCa2.3 activator (EC50 values are 14 and 5.6 µM respectively). Displays little or no activity at KCa2.1 and KCa3.1 channels. Reduces dopaminergic neuron activity and inhibits dopamine release.
Solubility & Handling
Storage instructions
+4°C
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.